These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8444512)

  • 1. A dynamical model for the separation of secondary resistance from tolerance to nitroglycerin infusion.
    Milicević G; Vrhovac B; Planinc D
    Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):12-7. PubMed ID: 8444512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of tolerance in continuous nitroglycerin infusion].
    Niestegge H; Cordes G; Blümchen G
    Herz; 1989 Feb; 14(1):66-70. PubMed ID: 2493413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How long can an escalation of dose override tolerance to the hypotensive efficacy of nitroglycerin infusion in coronary care patients.
    Milicevic G; Goldner V; Vrhovac B; Prpic H; Planinc D; Majsec M
    Cardiovasc Drugs Ther; 1999 Nov; 13(6):531-6. PubMed ID: 10686663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of the intravenous nitroglycerin dose on the appearance of drug tolerance].
    Barranco F; Lesmes A; Irles J; Peñas L; Schiaffino S; Ballesteros J; Pomares J
    Med Clin (Barc); 1995 Mar; 104(11):407-10. PubMed ID: 7715258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroglycerin in acute myocardial infarction.
    Jugdutt BI
    Can J Cardiol; 1989 Mar; 5(2):110-6. PubMed ID: 2495850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic effects of percutaneous trinitrin].
    Page A; Ledain L; Gateau P; Besse P
    Arch Mal Coeur Vaiss; 1981 Apr; 74(4):453-61. PubMed ID: 6786243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal of intravenous glyceryl trinitrate: absence of rebound phenomena with transition to oral isosorbide dinitrate.
    Kelly EA; Ahmed RM; Horowitz JD
    Clin Exp Pharmacol Physiol; 2005 Apr; 32(4):269-72. PubMed ID: 15810990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitroglycerin infusion after percutaneous coronary intervention does not influence short- and long-term outcome--a prospective NAPI (Nitroglycerin Administration after Percutaneous Intervention) study.
    Foryś J; Peruga J; Plewka M; Lipiec P; Jasińska A; Krzemińska-Pakuła M; Kasprzak J
    Kardiol Pol; 2007 Jul; 65(7):789-803; discussion 804-5. PubMed ID: 17694461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenous infusions of nitroglycerin in unstable stenocardia].
    Karpov IuA; Noeva EA; Ruda MIa
    Klin Med (Mosk); 1990 Feb; 68(2):39-43. PubMed ID: 2110600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance with low dose intravenous nitroglycerin therapy in acute myocardial infarction.
    Jugdutt BI; Warnica JW
    Am J Cardiol; 1989 Sep; 64(10):581-7. PubMed ID: 2506751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diltiazem versus intravenous nitroglycerin in the treatment of unstable angina pectoris. A randomized study].
    Castro P; Corbalán R; Vergara I; Kunstmann S
    Rev Med Chil; 1995 Jul; 123(7):823-9. PubMed ID: 8560112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the usage of intravenous iloprost and nitroglycerin for pulmonary hypertension during valvular heart surgery.
    Baysal A; Bilsel S; Bulbul OG; Kayacioglu I; Idiz M; Yekeler I
    Heart Surg Forum; 2006; 9(1):E536-42. PubMed ID: 16387672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects of intravenous nitroglycerin or sodium nitroprusside infusion on the blood pressure in patients with acute myocardial infarction].
    Wu Y
    Zhonghua Hu Li Za Zhi; 1997 Dec; 32(12):696-8. PubMed ID: 10455598
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed preconditioning-mimetic actions of nitroglycerin in patients undergoing exercise tolerance tests.
    Jneid H; Chandra M; Alshaher M; Hornung CA; Tang XL; Leesar M; Bolli R
    Circulation; 2005 May; 111(20):2565-71. PubMed ID: 15897341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyvinylchloride containers do not influence the hemodynamic response to intravenous nitroglycerin.
    McCollom RA; Lange B; Bryson SM; Levine M; Ewing K; Rabkin SW
    Can J Hosp Pharm; 1993 Aug; 46(4):165-70. PubMed ID: 10128359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis.
    Levy P; Compton S; Welch R; Delgado G; Jennett A; Penugonda N; Dunne R; Zalenski R
    Ann Emerg Med; 2007 Aug; 50(2):144-52. PubMed ID: 17509731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of preoperative intravenous nitroglycerin on in-hospital outcomes after coronary artery bypass grafting for unstable angina.
    Ali IS; Buth KJ; Maitland A
    Am Heart J; 2004 Oct; 148(4):727-32. PubMed ID: 15459607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin].
    Xie CL; Meng SR; Wang W; Chen SM; Li P; Feng XG
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):839-42. PubMed ID: 18504215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of continuous versus intermittent treatment with transdermal nitroglycerin on pacing-induced preconditioning in conscious rabbits.
    Szilvassy Z; Ferdinandy P; Nagy I; Jakab I; Koltai M
    Br J Pharmacol; 1997 Jun; 121(3):491-6. PubMed ID: 9179391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous nitroglycerin tolerance in patients with ischemic cardiomyopathy and congestive heart failure.
    Earl GL; Stanek EJ; Spinler SA
    Pharmacotherapy; 1998; 18(1):203-9. PubMed ID: 9469695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.